Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
09/2005
09/09/2005CA2558255A1 Process for producing phospholipid containing long chain polyunsaturated fatty acid as constituent thereof and utilization of the same
09/09/2005CA2557362A1 Process for the carbonylation of ethylenically or acetylenically unsaturated compounds
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/07/2005EP1571172A1 Polymeric, phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions
09/07/2005EP1571152A1 Amorphous 3-Pyridil-1-Hydroxyethyliden-1,1-Biphosphonic acid monosodium salt and process for the preparation thereof .
09/07/2005EP1569946A1 Colchicine derivatives, preparation method and use thereof
09/07/2005EP1569926A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569925A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569917A1 Pyrazine-based tubulin inhibitors
09/07/2005EP1569912A2 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
09/07/2005EP1569895A1 Prodrugs of gaba analogs, compositions and uses thereof
09/07/2005EP1569663A2 Ifosfamide compositions for parenteral administration and a process for their preparation
09/07/2005EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
09/07/2005EP0970038B2 Process for the carbonylation of ethylene
09/07/2005CN1665825A Use of certain diluents for making bisphosphonic acids
09/07/2005CN1665813A Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
09/07/2005CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/07/2005CN1665793A Ionic liquids
09/07/2005CN1665598A Collecting agent for sulphidic ores
09/07/2005CN1218065C A process for the purification of organometallic compounds or heteroatomic organic compounds with hudrogenated getter alloys
09/07/2005CN1217660C IL-8 receptor antagonists
09/06/2005US6939983 Alkyl group VA metal compounds
09/06/2005US6939969 8-quinolinyl amine ligands for metal complexes
09/06/2005US6939888 Heterocyclic amides such as 3-(2-chloro-6-methoxyphenyl)-5-isopropyl-5-methyl-4-acetoxy-3-pyrrolidine-2 -one, used as insecticides or miticides
09/06/2005US6939882 Fungicides
09/03/2005CA2498177A1 Amorphous 3-pyridil-1-hydroxyethyliden-1,1-biphosphonic acid monosodium salt and process for the preparation thereof
09/01/2005WO2005080587A2 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation
09/01/2005WO2005080454A1 (meth)acrylamide containing phosphorus compound acid residue, polymer made therefrom, use of the same, and processes for producing these
09/01/2005WO2005080411A1 3’-terminal nucleoside unit containing phosphoramidite
09/01/2005WO2005080407A1 Derivatised phospholipids
09/01/2005WO2005080406A2 Compounds for the inhibition of undesired cell proliferation and use thereof
09/01/2005WO2005080341A1 Ionic uv-a sunscreens and compositions containing them
09/01/2005WO2005079378A2 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
09/01/2005WO2005060647A3 Prodrugs of selective androgen receptor modulators and methods of use thereof
09/01/2005WO2005042546A3 Diazaphosphacycles
09/01/2005US20050192457 Process for the carbonylation of ethylenically or acetylenically unsaturated compounds
09/01/2005US20050192347 Urea and thiourea compounds and compositions for cholesterol management and related uses
09/01/2005US20050192246 Pharmacologically active agents containing esterified phosphonates and methods for use thereof
09/01/2005US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections
09/01/2005US20050190182 Data-driven layout engine
09/01/2005DE19964224B4 Pharmazeutische Mittel enthaltend Calcium-Komplex von Pharmaceutical preparations containing calcium complex of [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-säure-.kappa.N6,.kappa.N9,.kappa.011]1-oxidato(6-)]-, tetrahydrogen (MS-325) und dessen Salze sowie Verfahren zur Herstellung der Mittel tetra hydrogen (MS-325) and salts thereof as well as methods for preparing the compositions
09/01/2005CA2556868A1 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation
09/01/2005CA2556594A1 3'-end nucleoside unit comprising phosphoramidite
08/2005
08/31/2005EP1568701A1 Transition metal complex having diphosphine complex as ligand
08/31/2005EP1567612A1 Electroluminescent materials and devices
08/31/2005EP1567535A1 Bidentate c,p chiral phosphine ligands
08/31/2005EP1567534A1 Process for the synthesis of cycloorganylphosphanes and di(alkali metal/alkaline earth metal) oligophosphanediides
08/31/2005EP1567533A2 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
08/31/2005EP1567532A1 Oxazolidinone and / or isoxazoline derivatives as antibacterial agents
08/31/2005EP1567478A1 Method of producing nitrile compounds from ethylenically-unsaturated compounds
08/31/2005EP1567476A2 N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor
08/31/2005EP1567468A2 A selective synthesis of organophosphites
08/31/2005EP1483276B1 Ferrocenyl ligands and the use thereof in catalysis
08/31/2005EP1255761B1 Silicon containing compounds from michael - type addition reactions useful as monomers and macromers
08/31/2005CN1662592A Low acidity phosphate esters
08/31/2005CN1662579A Blocked mercaptosilane hydrolyzates as coupling agents for mineral-filled elastomer compositions
08/31/2005CN1662499A Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
08/31/2005CN1662495A Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662491A Phthalamide derivative, agricultural or horticultural insecticide, and method of use thereof
08/31/2005CN1660862A Method for synthesizing triphenyl phosphine dichloride
08/31/2005CN1660861A Medication towards target of bone, synthetic method and application
08/31/2005CN1660860A Method for preparing Alendronic acid
08/31/2005CN1660859A Process for the preparation of an alkenyl phosphonic acid derivative
08/31/2005CN1660858A Process for preparation of dialkylphosphinic salts
08/31/2005CN1660857A Salts of dialkylphosphinic acids
08/31/2005CN1216890C Cyclipostins, method for their production and use of same
08/31/2005CN1216889C Bidentate ligands useful in catalyst system
08/31/2005CN1216888C Method for producing N-phosphonomethylglycine and its salts
08/31/2005CN1216887C Preparation for 2-carboxyalkyl (phenyl) phosphoric acid
08/30/2005US6936700 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/30/2005US6936684 Reacting a salt of a phosphazenium cation and an inorganic anion, useful for polymerizing an alkylene oxide compound while using phosphazenium catalyst system free of metal
08/30/2005US6936631 Bicyclic imidazo-5-yl-amine derivatives
08/30/2005US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
08/30/2005US6936563 Coordination compounds and their use for the polymerization of olefins
08/30/2005US6936444 Process for the preparation of L-phosphinothricine by enzymatic transamination with aspartate
08/30/2005US6936298 Antithrombogenic membrane mimetic compositions and methods
08/30/2005US6936171 Process for catalyst recovery from hydrocyanation product mixtures
08/25/2005WO2005077961A1 Selenophosphinic amides, selenophosphoric amides, selenophosphoric chlorides, and processes for production of them
08/25/2005US20050187195 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans
08/25/2005US20050187193 Reducing plasma levels of apo B and LDL cholesterol and in decreasing plasma total cholesterol; restenosis following angioplasty; atherosclerosis, hypercholesterolemia; use with other drugs such as statins; e.g. diethyl alpha-(3,5-dimethoxy-4-hydroxyphenyl)-beta-(N-(3-pyridyl)-amino)-vinylphosphonate
08/25/2005US20050187116 Cyclic phospazene compounds and use thereof as additives of perfluoropolyether oils
08/25/2005US20050186700 Method for through-plating field effect transistors with a self-assembled monolayer of an organic compound as gate dielectric
08/25/2005US20050186447 Electroluminescent iridium compounds with phosphinoalkoxides and phenylpyridines or phenylpyrimidines and devices made with such compounds
08/25/2005US20050184277 Method for preparing arylphosphonite antioxidant
08/24/2005EP1566447A1 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase C regulation
08/24/2005EP1565425A1 Carbonylation of vinyl acetate
08/24/2005EP1504019B1 Platinum complexes having antitumor activity
08/24/2005EP1468003B1 Phosphinic pseudo-peptide derivatives
08/24/2005EP1409459A4 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
08/24/2005EP1294837B1 Oxoalcohol-based detergent
08/24/2005CN1659175A Multimer forms of mono- and bis-acylphosphine oxides
08/24/2005CN1659173A Process of making phosphordiamidite compounds
08/24/2005CN1658864A Stabilized ascorbic acid derivatives
08/24/2005CN1658842A Novel polymorphs and pseudopolymorphs of risedronate sodium
08/24/2005CN1658817A An aqueous dispersion containing pyrogenically prepared metal oxide particles and dispersants
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/24/2005CN1657532A Process for treating cglyphosate mother liquor
08/24/2005CN1657531A Process for treating production mother liquor of glyphosate
08/24/2005CN1657523A Cyclic compounds
08/24/2005CN1216062C Nucleotide analog composation